Featured Research

from universities, journals, and other organizations

'Tommy John' Surgery For Elbow Reconstruction Effective, But Number Of Baseball Players Requiring It Alarming

Date:
July 14, 2008
Source:
American Orthopaedic Society for Sports Medicine
Summary:
According to a new study, 83 percent of athletes who had "Tommy John" elbow reconstruction surgery were able to return to the same or better level of play. While reassuring to athletes, the study authors find the trend of more and more young athletes requiring the surgery, alarming.

Eighty-three percent of athletes who had "Tommy John" elbow reconstruction surgery were able to return to the same or better level of play, according to a study released today at the 2008 American Orthopaedic Society for Sports Medicine Annual Meeting at JW Marriott Orlando Grande Lakes. While reassuring to athletes, the study authors find the trend of more and more young athletes requiring the surgery, alarming.

"Before 1997 this surgery was performed on only 12 of 97 patients who were 18 or younger (12 percent)," said co-author E. Lyle Cain, MD, fellowship director for the American Sports Medicine Institute, Andrews Sports Medicine and Orthopaedic Center in Birmingham, Alabama. "In 2005 alone, 62 of the 188 operations performed, were on high school athletes, a third of the surgical group. The reality is that this surgery is successful and that's good. But a disturbing trend of younger kids needing the surgery is troubling. This should be a wake-up call to parents and coaches that specialization in baseball where kids don't get adequate time off is very dangerous."

"Tommy John" surgery is a procedure where a damaged elbow ligament (Ulnar Collateral Ligament or UCL) is replaced with a tendon from elsewhere in the body. The surgery is named for Hall of Fame pitcher Tommy John, who was the first person to have the surgery in 1974. John returned to the major leagues and went on to win 164 games after the surgery. Prior to this historic surgery, a UCL injury was a career-ending injury.

In the study, 743 patients who had the Tommy John surgery were contacted for follow-up evaluations and completed a questionnaire about their recovery. The majority of the patients were baseball players (94.5 percent), the remaining 5.5 percent were involved in track, football or other sports. The study found that 622 patients (83 percent) returned to the previous level of competition or higher. Of the major league players, 75.5 percent returned to the same level of play. For minor league players 56 percent returned to the same level or higher. The average time from surgery to full competition was 11.6 months after reconstruction, according to study results. Additionally about 10 percent of the patients had complications, mostly minor.

"The increase in the number of UCL reconstructions being done now can be attributed to many things: improved diagnostic techniques, heightened awareness, increased chance of positive outcome with current surgical techniques, but most importantly, the overuse of young throwing arms," said Dr. Cain. "In the past 10 years, year-round baseball leagues have proliferated. So the best young pitchers are throwing many more pitches and learning to throw more difficult pitches. It's great that the surgery is successful, but prevention of the injury should be the goal. Kids should be urged to rest and be careful about saving their arms, rather than leading to long-term problems at a young age."


Story Source:

The above story is based on materials provided by American Orthopaedic Society for Sports Medicine. Note: Materials may be edited for content and length.


Cite This Page:

American Orthopaedic Society for Sports Medicine. "'Tommy John' Surgery For Elbow Reconstruction Effective, But Number Of Baseball Players Requiring It Alarming." ScienceDaily. ScienceDaily, 14 July 2008. <www.sciencedaily.com/releases/2008/07/080712090831.htm>.
American Orthopaedic Society for Sports Medicine. (2008, July 14). 'Tommy John' Surgery For Elbow Reconstruction Effective, But Number Of Baseball Players Requiring It Alarming. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/07/080712090831.htm
American Orthopaedic Society for Sports Medicine. "'Tommy John' Surgery For Elbow Reconstruction Effective, But Number Of Baseball Players Requiring It Alarming." ScienceDaily. www.sciencedaily.com/releases/2008/07/080712090831.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins